基于弥散加权MRI的乏氧分数在前列腺癌FLAME试验队列中的预后价值
该研究在FLAME试验的前列腺癌放疗队列中计算基于弥散加权成像(DWI)的乏氧分数(HF),以0.28为阈值将410例患者分为低HF组(334例)和高HF组(76例),高HF组10年无病生存率显著更低(60% vs 77%,p=0.0016),且肿瘤控制概率曲线在高HF组始终较低,但增加D98%仍可改善肿瘤控制概率。
要点
- DWI-based HF以0.28为阈值可区分前列腺癌放疗预后高低。
- 高HF组10年无病生存率60%,低HF组77%(p=0.0016)。
- 高D98%不能完全补偿高HF,但增加D98%仍改善TCP。
核心结论
- 基于DWI的HF是局限期中高危前列腺癌放疗队列的独立预后因素。
- 高D98%不能完全补偿高HF,但增加D98%仍可观察到TCP改善。
研究设计与样本
- 计算FLAME试验中具有可用影像和随访数据患者的DWI-based HF。
- 在接受相似肿瘤近最小剂量(D98%)的亚队列中,用最大选择秩统计量法推导最佳HF阈值。
- 用该阈值进行Kaplan-Meier分析确定HF的预后价值,并估计TCP曲线评估HF亚组的剂量反应行为。
主要发现
- 410例患者纳入分析,包含100例临床失败。
- 最佳HF阈值0.28将全队列分为334例低HF和76例高HF患者。
- 10年无病生存率低HF组为77%(95%CI:72-82%),高HF组为60%(95%CI:49-73%)(p=0.0016)。
- TCP曲线显示两个亚组中肿瘤控制随D98%增加而增加,高HF组TCP始终较低。
关键数值与推荐
- 最佳HF阈值为0.28,用于区分低HF与高HF患者。
临床怎么用
- DWI-based HF可用于前列腺癌放疗前风险分层,识别高HF预后不良患者。
- 对高HF患者,增加D98%仍可能改善肿瘤控制概率,但无法完全消除高HF的不利影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although hypoxia is a prognostic factor in prostate cancer (PCa), it is not routinely assessed because it is difficult to measure. A diffusion weighted imaging (DWI) based model was proposed by Hompland et al. estimating oxygen levels in prostate tumor tissue (hypoxic fraction, HF). We investigated if DWI-based HF is a prognostic factor in a radiotherapy PCa cohort. MATERIALS AND METHODS: We calculated DWI-based HF for FLAME trial patients with available imaging and follow-up data. In a subcohort of patients receiving similar near-minimum dose to the tumor (D98%), we derived an optimal HF threshold to separate patients with low and high HF using maximally selected rank statistic method. Using this threshold, we performed Kaplan-Meier analysis to determine the prognostic value of HF. Furthermore, we estimated tumor control probability (TCP) curves to evaluate the dose-response behavior in these HF subgroups. RESULTS: There were 410 patients with 100 clinical failures included in the analysis. The optimal HF threshold of 0.28 separated the full cohort into 334 low and 76 high HF patients. The 10-year disease-free survival was 77% (95%CI: 72-82%) in the low and 60% (95%CI: 49-73%) in the high HF subgroup (p = 0.0016). The TCP curves showed tumor control increase with increasing D98% in both subgroups with consistently lower TCP in the high HF subgroup. CONCLUSION: The DWI-based HF is an independent prognostic factor in localized intermediate- and high-risk PCa radiotherapy cohort. Moreover, while high D98% cannot compensate fully for high HF, we still observed a TCP improvement when increasing D98%.
引用
- Menne Guricová K, van Houdt PJ, Fernandez Salamanca M, et al. Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort. Radiother Oncol. 2026. PMID: 42114601. doi:10.1016/j.radonc.2026.111578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。